In a prospective feasibility cohort study in four North East London primary care networks, 398 of 2,400 high-risk men aged 45-69 attended targeted prostate health checks, with markedly higher attendance in the test-first pathway than the telephone-first pathway: 22.9% vs 11.2%. The study, based on PSA-led risk-adapted screening for Black men and those with a family history of prostate cancer, found that primary care teams could identify high-risk patients from records — but that family history coding was often unreliable.

Why It Matters To Your Practice

• NPs and PAs are often the clinicians who make risk-adapted screening actually happen: identifying eligible patients, closing documentation gaps, counseling on PSA testing, and moving hesitant patients from outreach to action.

• This study suggests workflow design matters. A test-first approach roughly doubled attendance, giving frontline clinicians a practical lever to improve engagement without waiting for a specialist visit.

• For Black men and others at elevated prostate cancer risk, your outreach may be the deciding factor between missed opportunity and earlier detection of malignant neoplasm.

Clinical Benefits

• Using age and ethnicity data in primary care records was feasible for finding men at higher prostate cancer risk.

• Test-first invitations may reduce friction: patients complete community PSA testing first, then discuss results by phone, which can feel simpler and more actionable.

• Five prostate cancer cases were diagnosed, showing that targeted checks can translate into real case finding even in a feasibility program.

• Your ability to explain next steps clearly — elevated PSA, mpMRI, then biopsy if indicated — can improve follow-through and reduce drop-off.

Managing Risks

• PSA-based screening still carries risks of overdiagnosis and overtreatment, so shared decision-making remains essential.

• Family history coding was unreliable in this study, meaning chart review and patient conversation still matter. NPs and PAs are especially well positioned to catch what structured data miss.

• Disparities persisted for Black men, so outreach cannot be one-size-fits-all. Tailored messaging, culturally responsive counseling, and easier access points are likely necessary.

• Abnormal results require a dependable follow-up pathway to imaging and possible biopsy; strong care coordination is where advanced practice clinicians often lead.

The Bottom Line

• If your practice is considering targeted prostate screening, test-first outreach looks more effective than phone-first outreach for getting high-risk men in the door.

• This is frontline medicine, not backup work: NPs and PAs are central to identifying risk, earning trust, improving attendance, and ensuring abnormal PSA results do not get lost.

• The takeaway for practice is simple: better data, smarter outreach, and clinician-led follow-up can make risk-adapted prostate screening more workable in primary care.